Ontario has become the eighth Canadian province and territory to implement biosimilars transition (“switch”) policy, which moves patients from certain originator biologics to the biosimilar…
The Global RA Network (the “Network”) launched a new powerful advocacy tool – the RA Dashboard – as part of its initiatives to improve models…